Efficacy of Second-line Chemotherapy in Patients With Sensitive Relapsed Small-cell Lung Cancer-Reference-Cited by-同舟云学术

Efficacy of Second-line Chemotherapy in Patients With Sensitive Relapsed Small-cell Lung Cancer

Published:2019 Issue:6 Volume:33 Page:2229-2234
ISSN:0258-851X
Container-title:In Vivo
language:en
Short-container-title:In Vivo

Author:

WAKUDA KAZUSHIGE,MIYAWAKI TAICHI,MIYAWAKI ERIKO,MAMESAYA NOBUAKI,KAWAMURA TAKAHISA,KOBAYASHI HARUKI,OMORI SHOTA,NAKASHIMA KAZUHISA,ONO AKIRA,KENMOTSU HIROTSUGU,NAITO TATEAKI,MURAKAMI HARUYASU,MORI KEITA,ENDO MASAHIRO,TAKAHASHI TOSHIAKI

Publisher

Anticancer Research USA Inc.

Subject

Pharmacology,General Biochemistry, Genetics and Molecular Biology,Cancer Research

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and Relevant Risk Factor Assessment of Neoadjuvant Chemotherapy in Combination with Surgery in Limited-Stage Small-Cell Lung Cancer;Journal of Environmental Pathology, Toxicology and Oncology;2023

2. Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first‐line treatment including immune checkpoint inhibitors: A retrospective multicenter study ( TOPGAN 2021‐01);Thoracic Cancer;2022-11-21

3. Feasibility and safety of platinum-doublet therapy in patients with small-cell lung cancer in the third-line setting: A multi-institutional retrospective study;ONCOL LETT;2022

4. Platinum-Based Chemotherapy ‘Rechallenge’ in Advanced Non-ovarian Solid Malignancies;Clinical Oncology;2022-08

5. Platinum-doublet chemotherapy as second-line treatment for relapsed patients with small-cell lung cancer: A systematic review and meta-analysis;Lung Cancer;2021-06